Nantong Jinghua Pharmaceutical Co.,Ltd is a public pharmaceutical company in China which was established in 1957. As a comprehensive, advanced and innovative GMP company, we focus on R&D, manufacture and sales of APIs , intermediates. Our product Primidone, Fluorouracil, Phenobarbital, Phenylbutazone have got CEPs and also we have been inspected by FDA, TGA and cofepris.
We have a long and stable corporation with many world-famous pharmaceutical companies, like Sanofi, Novartis.
more >
Year of Establishment:
1957
Total Assets(USD):
Total Number of Staff:
100-500
Main Competitive Advantages:
Brand Name,International Approvals/Standards,Production Capacity,Buyers' Specifications Accepted,Reputation,Quality Service
Other Competitive Advantages:
Competitive GMP quality system for APIs, approved by US FDA, TGA, COFEPRIS, with Chinese GMP. Five APIs have CEP certificate.
Patents and Copyrights:
Business Type:
Manufacturer
R&D capacity:
Own Brand
Annual Turnover(USD):
Main Sales Markets:
North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Other Competitive Advantages:
Competitive GMP quality system for APIs, approved by US FDA, TGA, COFEPRIS, with Chinese GMP. Five APIs have CEP certificate.
Patents and Copyrights: